← All organizations
First clinical trial
Apr 20, 2017Last known activity
Apr 20, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT03064282Reponsible party - principal investigatorEarly Phase 1Apr 20, 2017
- NCT03064282Lead sponsorEarly Phase 1Apr 20, 2017
- NCT03090048Reponsible party - principal investigatorEarly Phase 1Apr 20, 2017
- NCT03090048Lead sponsorEarly Phase 1Apr 20, 2017
Details
- Last known activity
- Apr 20, 2017